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Different isolation procedures may preferentially extract
different isoforms, thereby causing the difference in results.
We agree that it is critical to compare the potential
of streptococcal pyrogenic exotoxin B and NAPlr as
nephritogenic antigens; however, for reliable comparison,
the same antigen and the same antibodies should be used.
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To the Editor: We read the recent article by Loredo-Osti
et al.1 proposing that a major gene with relatively large effect
on variation in urine calcium is segregating in French-
Canadian families with stone disease, which could be
localized using a quantitative trait locus mapping. We are
studying the genetic basis of hypercalciuric nephrolithiasis in
renal stone formers of North Indian origin. We have
phenotyped stone formers into normocalciuric and hyper-
calciuric groups based on their 24 h urinary calcium (U24Ca)
excretion. The hypercalciuric patients and their families were
investigated for linkage on chromosome 12, using five
microsatellite markers (D12S87, D12S339, D12S361,
D12S368, D12S90). A total of six families consisting of 18
affected and 19 unaffected individuals have been studied.
Positive logarithm of odds score (1.69, 1.433, 2.1, and 1.88)
were observed in four families and haplotype analysis
narrowed the disease locus between markers D12S87 and
D12S361. This region contains vitamin D receptor (VDR)
gene locus, suggesting a possible linkage of VDR gene with
hypercalciuric nephrolithiasis. We had earlier observed that
nephrolithiatic and hypercalciuric nephrolithiatic patients,
homozygous for bb genotype of VDR BsmI restriction site,
had significantly higher U24Ca (262.61724.28 mg/24 h and
387.34724.26 mg/24 h, Po0.05) than other genotypes. We
also found that stone formers with homozygous (FF)
genotype for FokI restriction site showed significantly higher
U24Ca excretion (350.28þ 24.05 mg/24 h, Po0.05).2 Our
results suggest that allelic variations in VDR gene may be
associated with varied urinary calcium excretion in nephro-
lithiatic and hypercalciuric nephrolithiatic patients. However,
further studies in different ethnic populations and with other
variants of VDR gene are needed to confirm the role of VDR
gene in renal stone disease.
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